Learn About A Now Approved Oral Rx Treatment for Moderate-to-Severe Atopic Dermatitis

Saturday, March 26 | 10:30 a.m.-11:15 a.m. ET


Join Pfizer | Product Session | Saturday, March 26 | 10:30 a.m.-11:15 a.m. ET

This program is independent and is not part of the official AAD Annual Meeting, as planned by its Scientific Assembly Committee. This program does not qualify for Continuing Medical Education (CME) Credit.